{"id":18959,"date":"2023-05-31T10:51:41","date_gmt":"2023-05-31T14:51:41","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?page_id=18959"},"modified":"2026-10-01T17:43:41","modified_gmt":"2026-10-01T21:43:41","slug":"translational-grants","status":"publish","type":"page","link":"https:\/\/www.emilysentourage.org\/pt_br\/translational-grants\/","title":{"rendered":"Subven\u00e7\u00f5es Translacionais"},"content":{"rendered":"
\n

Translational Grant Application Cycle\u2014Now Open<\/strong><\/p>\n

EE is currently accepting proposals for its 2026 Translational Grant funding cycle<\/strong>. Applications are due November 15, 2026, at 11:59 p.m. PT<\/strong>.<\/p>\n

Please review the information below for eligibility, funding priorities, application guidelines, and submission details.<\/p>\n

Questions? Contact us at research@emilysentourage.org<\/strong><\/a>.<\/p>\n<\/div>\n

Emily’s Entourage’s (EE) Translational Grant Program provides critical seed funding to innovative investigators with promising strategies that accelerate research and drug development for those in the final 10% of the CF community who do not benefit from CFTR modulators, including those with rare and nonsense mutations. <\/span><\/p>\n

For the 2026 cycle, EE will prioritize proposals that turn decisively toward clinical development and funding the development of technologies that already show promise. <\/b>EE is not<\/strong><\/em> looking to fund early screens intended to identify a lead or t<\/span>arget identification or basic mechanistic studies without a defined therapeutic candidate.<\/span><\/p>\n

Potential areas of interest include, but are not limited to, the following:<\/b><\/b><\/p>\n